ARTICLE | Clinical News
BIND-014: Phase II started
September 21, 2015 7:00 AM UTC
Bind began the open-label, international Phase II iNSITE 2 trial to evaluate IV BIND-014 in up to 160 patients with cholangiocarcinoma, advanced cervical cancer, advanced bladder cancer or advanced SC...